Log in

SHILPAMED Shilpa Medicare Limited NSE · India

Shilpa Medicare (SHILPAMED) news

Shilpa Medicare Limited is a public biotech or pharmaceutical company listed on NSE under the ticker SHILPAMED, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Shilpa Medicare news

We have not published a story on Shilpa Medicare yet. When there is news, it will appear here.

Questions about Shilpa Medicare

What is the ticker symbol of Shilpa Medicare?

Shilpa Medicare Limited trades under the ticker SHILPAMED on NSE.

Where is Shilpa Medicare listed?

Shilpa Medicare Limited is listed on NSE. Our directory also records these other listings: BSE:SHILPAMED.

Which country or territory is Shilpa Medicare listed under?

Our directory records Shilpa Medicare Limited under India.

What does Shilpa Medicare do?

Our directory classifies Shilpa Medicare Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Shilpa Medicare?

The ISIN recorded for Shilpa Medicare Limited is INE790G01031.

Does aibio.space cover Shilpa Medicare?

aibio.space lists Shilpa Medicare Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Shilpa Medicare?

Companies in our directory listed in the same country and business area as Shilpa Medicare: Starsource Multitrade, Parmax Pharma, Emcure Pharmaceuticals, Ortin Global, Sun Pharmaceutical Industries, Anuh Pharma.

Investor discussion: Shilpa Medicare

Members talk about Shilpa Medicare (SHILPAMED). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:SHILPAMED on TradingView.

Listing details

Shilpa Medicare Limited is a public biotech or pharmaceutical company listed on NSE under the ticker SHILPAMED, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Shilpa Medicare Limited
Ticker
SHILPAMED
Listing
NSE
Country or territory
India
Business scope
Pharmaceuticals: Major
ISIN
INE790G01031
Other listed symbols
BSE:SHILPAMED
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.